
Sign up to save your podcasts
Or


This week, the FDA approves single-use bronchoscopes; a study finds the Moderna COVID-19 vaccine is safe and effective in adolescents; CMS nixes the most-favored nation pricing model for Medicare Part B; and more.
Read the full coverage here:
Single-use bronchoscope receives FDA clearance
Moderna COVID-19 vaccine safe, efficacious in adolescents
Adoption of newer antifibrotic medications for IPF low in US in everyday practice: Study
FDA allows third dose of COVID-19 vaccine for immunocompromised patients
CMS nixes 'most-favored nation' pricing model for Medicare Part B
References:
Ali K, et al. N Engl J Med. 2021;doi:10.1057/NEJMoa2109522.
CMS proposed rule.
Dempsey TM, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202007-901OC.
Press Release.
Press Release.
By Abhishek Bhardwaj, MD5
1313 ratings
This week, the FDA approves single-use bronchoscopes; a study finds the Moderna COVID-19 vaccine is safe and effective in adolescents; CMS nixes the most-favored nation pricing model for Medicare Part B; and more.
Read the full coverage here:
Single-use bronchoscope receives FDA clearance
Moderna COVID-19 vaccine safe, efficacious in adolescents
Adoption of newer antifibrotic medications for IPF low in US in everyday practice: Study
FDA allows third dose of COVID-19 vaccine for immunocompromised patients
CMS nixes 'most-favored nation' pricing model for Medicare Part B
References:
Ali K, et al. N Engl J Med. 2021;doi:10.1057/NEJMoa2109522.
CMS proposed rule.
Dempsey TM, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202007-901OC.
Press Release.
Press Release.

121 Listeners

9 Listeners

31 Listeners

30 Listeners

5 Listeners

15 Listeners

5 Listeners

6 Listeners

5 Listeners